Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 518.12 Million USD | -3.37% |
| 2022 | 536.16 Million USD | 139.66% |
| 2021 | 223.72 Million USD | 194.94% |
| 2020 | 75.85 Million USD | 11.88% |
| 2019 | 67.79 Million USD | 32.28% |
| 2018 | 51.25 Million USD | 10.59% |
| 2017 | 46.34 Million USD | 50.26% |
| 2016 | 30.84 Million USD | 12.23% |
| 2015 | 27.48 Million USD | -3.24% |
| 2014 | 28.4 Million USD | 16.39% |
| 2013 | 24.4 Million USD | 10.83% |
| 2012 | 22.02 Million USD | 11.29% |
| 2011 | 19.78 Million USD | 20.73% |
| 2010 | 16.38 Million USD | -20.05% |
| 2009 | 20.49 Million USD | -19.19% |
| 2008 | 25.36 Million USD | -13.42% |
| 2007 | 29.3 Million USD | 21.36% |
| 2006 | 24.14 Million USD | 63.34% |
| 2005 | 14.78 Million USD | 22.23% |
| 2004 | 12.09 Million USD | -25.91% |
| 2003 | 16.32 Million USD | 32.49% |
| 2002 | 12.32 Million USD | 9.52% |
| 2001 | 11.24 Million USD | 25.6% |
| 2000 | 8.95 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 504.55 Million USD | -2.62% |
| 2024 Q2 | 491.96 Million USD | -2.5% |
| 2023 Q4 | 518.12 Million USD | -0.88% |
| 2023 Q3 | 522.71 Million USD | -1.92% |
| 2023 Q2 | 532.96 Million USD | -1.08% |
| 2023 Q1 | 538.81 Million USD | 0.49% |
| 2023 FY | 518.12 Million USD | -3.37% |
| 2022 Q1 | 223.53 Million USD | -0.09% |
| 2022 Q2 | 400.21 Million USD | 79.04% |
| 2022 Q3 | 412.66 Million USD | 3.11% |
| 2022 Q4 | 536.16 Million USD | 29.93% |
| 2022 FY | 536.16 Million USD | 139.66% |
| 2021 Q3 | 213.1 Million USD | 1.08% |
| 2021 FY | 223.72 Million USD | 194.94% |
| 2021 Q4 | 223.72 Million USD | 4.98% |
| 2021 Q1 | 218.1 Million USD | 187.53% |
| 2021 Q2 | 210.82 Million USD | -3.34% |
| 2020 Q2 | 60.91 Million USD | 0.04% |
| 2020 Q4 | 75.85 Million USD | 6.21% |
| 2020 Q1 | 60.89 Million USD | -10.18% |
| 2020 FY | 75.85 Million USD | 11.88% |
| 2020 Q3 | 71.42 Million USD | 17.24% |
| 2019 Q4 | 67.79 Million USD | 0.82% |
| 2019 Q3 | 67.24 Million USD | 3.83% |
| 2019 Q2 | 64.76 Million USD | 11.21% |
| 2019 Q1 | 58.23 Million USD | 13.63% |
| 2019 FY | 67.79 Million USD | 32.28% |
| 2018 Q1 | 40.27 Million USD | -13.11% |
| 2018 Q3 | 48.53 Million USD | 4.7% |
| 2018 Q4 | 51.25 Million USD | 5.59% |
| 2018 FY | 51.25 Million USD | 10.59% |
| 2018 Q2 | 46.35 Million USD | 15.11% |
| 2017 Q2 | 34.92 Million USD | 21.05% |
| 2017 Q4 | 46.34 Million USD | 17.52% |
| 2017 FY | 46.34 Million USD | 50.26% |
| 2017 Q1 | 28.84 Million USD | -6.47% |
| 2017 Q3 | 39.43 Million USD | 12.92% |
| 2016 Q2 | 27.3 Million USD | 8.75% |
| 2016 FY | 30.84 Million USD | 12.23% |
| 2016 Q4 | 30.84 Million USD | 7.97% |
| 2016 Q3 | 28.56 Million USD | 4.64% |
| 2016 Q1 | 25.1 Million USD | -8.66% |
| 2015 FY | 27.48 Million USD | -3.24% |
| 2015 Q1 | 25.45 Million USD | -10.4% |
| 2015 Q2 | 26.55 Million USD | 4.32% |
| 2015 Q3 | 26.58 Million USD | 0.12% |
| 2015 Q4 | 27.48 Million USD | 3.39% |
| 2014 Q2 | 23.92 Million USD | -0.26% |
| 2014 FY | 28.4 Million USD | 16.39% |
| 2014 Q4 | 28.4 Million USD | 8.36% |
| 2014 Q3 | 26.21 Million USD | 9.57% |
| 2014 Q1 | 23.98 Million USD | -1.7% |
| 2013 FY | 24.4 Million USD | 10.83% |
| 2013 Q1 | 20.32 Million USD | -7.72% |
| 2013 Q3 | 21.89 Million USD | 1.15% |
| 2013 Q2 | 21.64 Million USD | 6.52% |
| 2013 Q4 | 24.4 Million USD | 11.45% |
| 2012 Q1 | 20.21 Million USD | 2.17% |
| 2012 Q3 | 21.31 Million USD | 3.25% |
| 2012 FY | 22.02 Million USD | 11.29% |
| 2012 Q2 | 20.64 Million USD | 2.1% |
| 2012 Q4 | 22.02 Million USD | 3.33% |
| 2011 Q3 | 17.63 Million USD | 1.28% |
| 2011 Q4 | 19.78 Million USD | 12.21% |
| 2011 FY | 19.78 Million USD | 20.73% |
| 2011 Q1 | 16.07 Million USD | -1.89% |
| 2011 Q2 | 17.41 Million USD | 8.28% |
| 2010 FY | 16.38 Million USD | -20.05% |
| 2010 Q3 | 16.65 Million USD | -0.43% |
| 2010 Q4 | 16.38 Million USD | -1.58% |
| 2010 Q2 | 16.72 Million USD | -12.98% |
| 2010 Q1 | 19.21 Million USD | -6.25% |
| 2009 Q3 | 19.54 Million USD | -8.96% |
| 2009 Q4 | 20.49 Million USD | 4.86% |
| 2009 Q1 | 23.37 Million USD | -7.85% |
| 2009 Q2 | 21.47 Million USD | -8.14% |
| 2009 FY | 20.49 Million USD | -19.19% |
| 2008 FY | 25.36 Million USD | -13.42% |
| 2008 Q3 | 27.38 Million USD | -4.41% |
| 2008 Q4 | 25.36 Million USD | -7.36% |
| 2008 Q2 | 28.64 Million USD | 4.3% |
| 2008 Q1 | 27.46 Million USD | -6.26% |
| 2007 Q3 | 27.43 Million USD | 7.19% |
| 2007 Q4 | 29.3 Million USD | 6.81% |
| 2007 Q2 | 25.59 Million USD | 11.39% |
| 2007 Q1 | 22.97 Million USD | -4.83% |
| 2007 FY | 29.3 Million USD | 21.36% |
| 2006 FY | 24.14 Million USD | 63.34% |
| 2006 Q2 | 17.42 Million USD | 6.96% |
| 2006 Q4 | 24.14 Million USD | 15.94% |
| 2006 Q1 | 16.29 Million USD | 10.22% |
| 2006 Q3 | 20.82 Million USD | 19.49% |
| 2005 Q2 | 12.94 Million USD | 14.16% |
| 2005 Q4 | 14.78 Million USD | 7.07% |
| 2005 FY | 14.78 Million USD | 22.23% |
| 2005 Q1 | 11.34 Million USD | -6.22% |
| 2005 Q3 | 13.8 Million USD | 6.63% |
| 2004 Q2 | 9.76 Million USD | -44.13% |
| 2004 Q1 | 17.47 Million USD | 7.08% |
| 2004 Q3 | 11.48 Million USD | 17.59% |
| 2004 Q4 | 12.09 Million USD | 5.3% |
| 2004 FY | 12.09 Million USD | -25.91% |
| 2003 Q4 | 16.32 Million USD | 0.0% |
| 2003 FY | 16.32 Million USD | 32.49% |
| 2002 FY | 12.32 Million USD | 9.52% |
| 2001 FY | 11.24 Million USD | 25.6% |
| 2000 FY | 8.95 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -910.889% |
| BrainsWay Ltd. | 15.31 Million USD | -3283.316% |
| Cerus Corporation | 144.3 Million USD | -259.048% |
| Envoy Medical, Inc. | 9.4 Million USD | -5410.753% |
| electroCore, Inc. | 8.94 Million USD | -5692.297% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -9599.008% |
| IceCure Medical Ltd | 4.24 Million USD | -12099.694% |
| Inogen, Inc. | 121.38 Million USD | -326.852% |
| OrthoPediatrics Corp. | 72.56 Million USD | -614.049% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -1651.533% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -16183.164% |
| MaxCyte, Inc. | 36.1 Million USD | -1334.96% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -27938.216% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -121730.272% |
| Orthofix Medical Inc. | 326.58 Million USD | -58.648% |
| PAVmed Inc | 57.13 Million USD | -806.805% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -1934.8% |
| RxSight, Inc. | 22.18 Million USD | -2235.141% |
| Sight Sciences, Inc. | 46.43 Million USD | -1015.774% |
| SI-BONE, Inc. | 61.05 Million USD | -748.683% |
| TELA Bio, Inc. | 59.16 Million USD | -775.693% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -354.616% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -4921.039% |
| Acutus Medical, Inc. | 54.83 Million USD | -844.804% |
| Talis Biomedical Corporation | 29.22 Million USD | -1672.93% |
| Spectral AI, Inc. | 12.4 Million USD | -4078.058% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -2139.652% |
| CVRx, Inc. | 39.28 Million USD | -1218.978% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -4232.812% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -21227.996% |
| Bioventus Inc. | 589.79 Million USD | 12.152% |
| Venus Concept Inc. | 107.1 Million USD | -383.76% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -902.886% |
| LivaNova PLC | 1.15 Billion USD | 55.022% |
| 908 Devices Inc. | 37.49 Million USD | -1282.025% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 26.35% |
| Nemaura Medical Inc. | 26.37 Million USD | -1864.259% |
| NeuroPace, Inc. | 86.99 Million USD | -495.562% |
| LENSAR, Inc. | 22.4 Million USD | -2212.111% |
| Apyx Medical Corporation | 52.31 Million USD | -890.33% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -1666.643% |
| BioSig Technologies, Inc. | 4.68 Million USD | -10959.146% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -787.695% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -2311.211% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 76.386% |
| Axonics, Inc. | 82.35 Million USD | -529.101% |
| Outset Medical, Inc. | 190.91 Million USD | -171.388% |
| IRIDEX Corporation | 24.91 Million USD | -1979.638% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -317.957% |
| IRadimed Corporation | 20.73 Million USD | -2398.662% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -30851.075% |
| INVO Bioscience, Inc. | 19.99 Million USD | -2491.258% |
| Telesis Bio, Inc. | 40.87 Million USD | -1167.636% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -1170.209% |
| Varex Imaging Corporation | 668.6 Million USD | 22.507% |
| Quipt Home Medical Corp. | 136.29 Million USD | -280.152% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -14405.067% |
| Pulmonx Corporation | 60.63 Million USD | -754.478% |
| Dynatronics Corporation | 11.78 Million USD | -4298.268% |
| Modular Medical, Inc. | 2.27 Million USD | -22704.621% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -12649.04% |
| Semler Scientific, Inc. | 6.27 Million USD | -8163.493% |
| InMode Ltd. | 75.91 Million USD | -582.51% |
| Bruker Corporation | 2.83 Billion USD | 81.734% |
| Cytosorbents Corporation | 29.98 Million USD | -1627.907% |
| DexCom, Inc. | 4.19 Billion USD | 87.652% |
| Align Technology, Inc. | 2.45 Billion USD | 78.881% |
| Viveve Medical, Inc. | 10.84 Million USD | -4676.629% |
| ZimVie Inc. | 795.85 Million USD | 34.897% |
| Movano Inc. | 5.97 Million USD | -8575.837% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -395.312% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -121730.272% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -4232.812% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 18.92% |
| Profound Medical Corp. | 12.66 Million USD | -3990.688% |
| Insulet Corporation | 1.85 Billion USD | 72.076% |
| enVVeno Medical Corporation | 2.43 Million USD | -21178.07% |
| Surmodics, Inc. | 65.82 Million USD | -687.143% |
| iCAD, Inc. | 8 Million USD | -6375.704% |
| Nuwellis, Inc. | 6.78 Million USD | -7541.903% |
| Biotricity, Inc. | 35.91 Million USD | -1342.453% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -132.292% |
| Aethlon Medical, Inc. | 2.47 Million USD | -20794.925% |
| InspireMD, Inc. | 8.14 Million USD | -6263.56% |
| PAVmed Inc. | 57.13 Million USD | -806.805% |
| BIOLASE, Inc. | 35.34 Million USD | -1365.772% |
| Beyond Air, Inc. | 29.77 Million USD | -1640.121% |
| FONAR Corporation | 57.45 Million USD | -801.745% |
| AxoGen, Inc. | 101.16 Million USD | -412.17% |
| Vivani Medical, Inc. | 25.03 Million USD | -1969.504% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -490.142% |
| Inari Medical, Inc. | 209.32 Million USD | -147.52% |
| UFP Technologies, Inc. | 118.04 Million USD | -338.918% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -3982.749% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -23603.823% |
| Tenon Medical, Inc. | 5.56 Million USD | -9207.006% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -29024.283% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -2838.174% |
| AdaptHealth Corp. | 3.15 Billion USD | 83.568% |
| Sintx Technologies, Inc. | 6.59 Million USD | -7758.653% |
| NanoVibronix, Inc. | 2.68 Million USD | -19189.687% |
| Quanterix Corporation | 78.08 Million USD | -563.543% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -14405.067% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -10506.366% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 50.405% |
| TransMedics Group, Inc. | 568.84 Million USD | 8.917% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -3005.869% |
| NeuroMetrix, Inc. | 1.33 Million USD | -38765.177% |
| Hyperfine, Inc. | 9.8 Million USD | -5186.949% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -107.045% |
| Biomerica, Inc. | 2.66 Million USD | -19356.29% |
| Bone Biologics Corporation | 831.4 Thousand USD | -62218.95% |
| AVITA Medical, Inc. | 19.86 Million USD | -2508.158% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -26151.48% |
| Silk Road Medical, Inc | 114.15 Million USD | -353.863% |